Fee schedule 2015 :The wait continues for Medicare’s decision on new codes and pay for drug screens

Why This Topic Matters

Drug testing billing was in transition, with Medicare decisions potentially affecting which code set would be used by different payers and how practices would need to prepare their charge capture, super bills, and software. The article is relevant to organizations that bill for laboratory drug screens, drug assay, and confirmation services.

Article Sections

1. Clinical lab fee schedule, 2015 — preliminary determination

   Covers Medicare’s proposed-rule activity for the 2015 clinical laboratory fee schedule and the status of public comments and final rule timing. It discusses the broader context of how the agency was approaching payment for drug screen-related services.

2. Final 2015 Medicare physician fee schedule

   Summarizes the physician fee schedule release and its relationship to drug testing reporting for 2015. It also notes the presence of relevant addendum material and the uncertainty surrounding final payer direction.